Target intelligence / Profile preview

Bacterial 50S ribosomal subunit (50S subunit) (50S subunit)

Target
50S subunit
Molecular classification
Ribonucleoprotein, Enzyme, Other
01

Overview

The bacterial 50S ribosomal subunit is the larger component of the prokaryotic 70S ribosome, primarily composed of 23S ribosomal RNA (rRNA), 5S rRNA, and approximately 33 ribosomal proteins (PubMed: PMID 11514518). Its fundamental biological role is to catalyze the peptidyl transferase reaction, which forms peptide bonds between amino acids during translation, and to provide a channel for the nascent polypeptide to exit the ribosome. This subunit is a major target for various classes of antibiotics because of the structural differences between prokaryotic and eukaryotic ribosomes, allowing for selective toxicity. Clindamycin, a lincosamide antibiotic, binds specifically to the 23S rRNA component of the 50S subunit at the peptidyl transferase center (StatPearls: Clindamycin, 2023). This binding prevents the attachment of aminoacyl-tRNA and inhibits the translocation step, effectively halting bacterial protein synthesis. Clinically, targeting the 50S subunit is essential for treating infections caused by Gram-positive cocci and anaerobic bacteria, though resistance mediated by rRNA methylation (erm genes) remains a significant therapeutic challenge (PubMed: PMID 15544330).

Other names
Large ribosomal subunit50S ribosome23S ribosomal RNAProkaryotic 50S subunitPeptidyl transferase center
02

Mechanism of action

Clindamycin binds to the 50S ribosomal subunit of susceptible bacteria, specifically at the 23S rRNA component within the peptidyl transferase center, which inhibits the formation of peptide bonds and prevents the translocation of the peptide chain, thereby halting bacterial protein synthesis (StatPearls: Clindamycin, 2023; PubMed: PMID 11514518).

03

Biological functions

Protein synthesisTranslationPeptidyl transferase activityOther
04

Disease associations

Infection
05

Safety considerations

Clostridioides difficile-associated diarrhea (CDAD)Pseudomembranous colitisDevelopment of antibiotic resistance (MLSB phenotype)Gastrointestinal distress
06

Interacting drugs

Clindamycin

10 more in the full profile.

07

Biomarkers

erm gene expression (erythromycin ribosome methylation)cfr gene presence23S rRNA mutationsD-test (for inducible clindamycin resistance)

Beyond the preview

Go deeper on Bacterial 50S ribosomal subunit (50S subunit) (50S subunit).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial 50S ribosomal subunit (50S subunit) (50S subunit).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call